Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_assertion description "[A preferred panel would also include CD20, CD117, CD28 and CD27; 4) discrepancies between the percentage of plasma cells detected by flow cytometry and morphology are primarily related to sample quality and it is, therefore, important to determine that marrow elements are present in follow-up samples, particularly normal plasma cells in MRD negative cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_assertion evidence source_evidence_literature NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_assertion SIO_000772 18268286 NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_assertion wasDerivedFrom befree-20150227 NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_assertion wasGeneratedBy ECO_0000203 NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP291638.RAS6V-InnUx2v4ovKmEfncTMkWyAY5VFKCp7QQjjkSmPM130_provenance.